SAVA (cassavasciences.com) Net Income

SAVA (cassavasciences.com) - company brandmark

Cassava Sciences, Inc. (SAVA) focuses on restoring brain proteins to combat Alzheimer's through the drug simufilam. The company's net earnings reflect the market consensus, with the latest figure standing at -0.10. The company is currently completing pivotal Phase 3 trials that will determine its future. High R&D expenditures and strict FDA oversight create significant barriers to entry for new players.

Cassava Sciences, Inc. (SAVA) Company Net Income: for the period 07/04/2022 - 03/11/2026

Financial and market metric breakdowns for Cassava Sciences (SAVA)

- stock value and consensus price forecast:
Market Price Cassava Pharma|SAVA - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation Cassava Pharma|SAVA - Enterprise Value
- company book value details:
Book Value per Share Cassava Sciences|SAVA - Company Book Value|Market Capitalization to Book Value cassavasciences.com|SAVA - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Cassava Sciences, Inc.|SAVA - Long-Term Debt to Capital|Short-Term Debt to Capital Cassava Sciences Inc|SAVA - Company Total Debt|Debt to Book Capitalization Ratio Cassava Pharma|SAVA - Company Long-Term Debts|Company Short-Term Debts Cassava Sciences|Intermediate Coverage Ratio cassavasciences.com
- earnings and market multiples details:
SAVA - Company Net Income
Summary company analysis:Cassava Pharma, SAVA
Mass-produced product of Cassava Sciences

The development of Alzheimer's disease therapy makes the business of Cassava Sciences, Inc. (SAVA) insensitive to market cycles, yet highly dependent on clinical trial outcomes. This profit magnitude trend captures the daily net income based on current quotes, allowing investors to decouple objective financial performance from speculative expectations and assess the risk of capital loss when buying at peaks.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Net Profit AXSM|Net Profit ACADIA Pharma (ACAD)|Company Net Income Xenon Pharmaceuticals Inc XENE|Net Financial Result Viking Therapeutics Corp (VKTX)|SUPN - Company Net Income|Net Financial Result catalystpharma.com CPRX|DNLI: Net Profit|Harmony Biosciences Inc (HRMY) - Net Profit|Net Income BHVN|Company Net Income AMLX|Net Profit TRVI|Net Profit praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|PRTA - Company Net Income|Net Financial Result Alector, Inc. ALEC|ANNX: Net Profit|Net Income Omeros|NGNE (Neurogene) - Net Profit|AC Immune S.A. (ACIU) - Net Financial Result|Net Profit VYGR|NMRA - Company Net Income|Company Net Income Scilex Holding Company SCLX|TVGN: Company Profit|Alpha Cognition Corp - Net Profit|cogrx.com (CGTX) - Net Income|IKT: Net Profit|Company Net Income Assertio (ASRT)|Company Net Income Coya Therapeutics Inc|VistaGen Therapeutics Inc (VTGN) - Net Financial Result|Net Income OVID (Ovid Therapeutics Inc.)|ABOS (Acumen Pharmaceuticals Inc.) - Final Profit|Net Profit CRVO (CervoMed Inc)|Net Financial Result Alterity Therapeutics Ltd. (ATHE)|CLNN - Company Net Income|PEPG (PepGen Inc.) - Company Profit|JUNS: Net Profit|Net Income Relmada Therapeutics Inc|Net Income ANVS|Grace Tx (GRCE) - Net Financial Result|Company Net Income Firefly Neuroscience, Inc (AIFF)|Net Financial Result anewmeds.com|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|Net Profit Reviva Pharmaceuticals Holdings Inc. RVPH|MTVA: Net Income|NRXS: Company Net Income|HSDT: Net Profit|Passage Bio (PASG) - Net Profit|Company Net Income Neuphoria Therapeutics, Inc.|Company Profit NERV (Minerva Neurosciences Inc)|Net Profit ATHA|ADXN - Company Net Income|Alzamend Neuro - Net Income|Net Profit Cyclerion Therapeutics Inc. CYCN|PTIX - Company Net Income|Final Profit KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Company Net Income|Company Net Income Avenue Therapeutics Inc (ATXI)|BCLI (Brainstorm Cell) - Net Profit|Net Income caratherapeutics.com (CARA)|Net Profit CHRO|Net Profit eliemtx.com (ELYM)|Company Net Income Intra-Cellular Therapies, Inc. ITCI|Net Financial Result Longboard (LBPH)|MRNS - Company Net Income|Net Financial Result nkgenbiotech.com NKGN|NRBO: Net Profit|Sage Therapeutics Inc. (SAGE) - Net Profit|Net Income SNPX|Company Net Income TRVN|Net Profit VIGL|Net Profit Anew Medical Inc. (WENA)|Cerevel Therapeutics, Inc. - Net Income